Aptamer Group (LSE:APTA) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Aptamer Group's Capital Expenditure for the six months ended in Dec. 2023 was £-0.04 Mil. Its Operating Income for the six months ended in Dec. 2023 was £-1.87 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Aptamer Group Capex-to-Operating-Income Historical Data

The historical data trend for Aptamer Group's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Capex-to-Operating-Income Chart

Aptamer Group Annual Data

Trend

Mar19

Mar20

Jun22

Jun23

Capex-to-Operating-Income

Aptamer Group Semi-Annual Data
	Mar19	Mar20	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Operating-Income	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Aptamer Group's Capex-to-Operating-Income

For the Biotechnology subindustry, Aptamer Group's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptamer Group's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Aptamer Group's Capex-to-Operating-Income falls into.

Aptamer Group Capex-to-Operating-Income Calculation

Aptamer Group's Capex-to-Operating-Income for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-2.028)	/	-8.157
	=	N/A

Aptamer Group's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-0.04)	/	-1.872
	=	N/A

Aptamer Group (LSE:APTA) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Aptamer Group Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptamer Group (LSE:APTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Innovation Way, Windmill House, York, GBR, YO10 5BR

Website

https://www.aptamergroup.com

Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines